Canadian application, no grantCanada
A method of treating premenstrual dysphoric disorder with escitalopram
CA 2483920 A1 · Owner: H. Lundbeck A/S · Inventors: Sanchez, Connie
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a method of treating the symptoms of premenstrual dysphoric disorder (PMDD) in a patient in need thereof by administering an effective amount of escitalopram or a pharmaceutically acceptable, salt thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 7, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 7, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 7, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 7, 2003
GrantedNo grant recorded
Term endedNovember 7, 2023
Patent numberCA 2483920 A1
Classification (IPC)A61K31/34 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.